Invasive Fungal Infections in Chronic Lymphoproliferative Disorders: a Monocentric Retrospective Study

Overview

Journal Haematologica

Specialty Hematology

Date 2016 Nov 19

PMID 27856512

Citations 20

Authors

Maria Chiara Tisi

Stefan Hohaus

Annarosa Cuccaro

Idanna Innocenti

Elena De Carolis

Tommaso Za

Francesco DAlo

Luca Laurenti

Luana Fianchi

Simona Sica

Maurizio Sanguinetti

Valerio De Stefano

Livio Pagano

Affiliations

Soon will be listed here.

Citing Articles

Invasive fungal infections in patients with multiple myeloma: a possible growing problem in hematology and infectious diseases.

Valkovic T, Marcelic L, Valkovic F Ther Adv Infect Dis. 2024; 11:20499361241238518.

PMID: 38545449 PMC: 10966984. DOI: 10.1177/20499361241238518.

Severe Fatal Mucormycosis in a Patient with Chronic Lymphocytic Leukaemia Treated with Zanubrutinib: A Case Report and Review of the Literature.

Maggioni G, Fedrigo M, Visentin A, Carturan E, Ruocco V, Trentin L Curr Oncol. 2023; 30(9):8255-8265.

PMID: 37754514 PMC: 10529318. DOI: 10.3390/curroncol30090599.

Invasive Pulmonary Aspergillosis.

Ledoux M, Herbrecht R J Fungi (Basel). 2023; 9(2).

PMID: 36836246 PMC: 9962768. DOI: 10.3390/jof9020131.

Case Report: Invasive Fungal Infection and Daratumumab: A Case Series and Review of Literature.

Farina F, Ferla V, Marktel S, Clerici D, Mastaglio S, Perini T Front Oncol. 2022; 12:867301.

PMID: 35928865 PMC: 9344135. DOI: 10.3389/fonc.2022.867301.

Cryptococcosis in a patient with multiple myeloma receiving pomalidomide: a case report and literature review.

Chastain D, Golpayegany S, Henao-Martinez A, Jackson B, Stoudenmire L, Bell K Ther Adv Infect Dis. 2022; 9:20499361221112639.

PMID: 35898694 PMC: 9310278. DOI: 10.1177/20499361221112639.

References

De Pauw B, Walsh T, Donnelly J, Stevens D, Edwards J, Calandra T . Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group.... Clin Infect Dis. 2008; 46(12):1813-21. PMC: 2671227. DOI: 10.1086/588660. View

Stanzani M, Lewis R, Fiacchini M, Ricci P, Tumietto F, Viale P . A risk prediction score for invasive mold disease in patients with hematological malignancies. PLoS One. 2013; 8(9):e75531. PMC: 3784450. DOI: 10.1371/journal.pone.0075531. View

Teh B, Teng J, Urbancic K, Grigg A, Harrison S, Worth L . Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies. Haematologica. 2014; 100(1):e28-31. PMC: 4281332. DOI: 10.3324/haematol.2014.114025. View

Moreira J, Rabe K, Cerhan J, Kay N, Wilson J, Call T . Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls. Leukemia. 2012; 27(1):136-41. DOI: 10.1038/leu.2012.187. View

Francis S, Karanth M, Pratt G, Starczynski J, Hooper L, Fegan C . The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia. Cancer. 2006; 107(5):1023-33. DOI: 10.1002/cncr.22094. View

Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B . The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006; 91(8):1068-75. View

Offidani M, Corvatta L, Polloni C, Gentili S, Brioni A, Visani G . Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide. Leuk Lymphoma. 2011; 52(5):776-85. DOI: 10.3109/10428194.2011.555027. View

Liu J, Huang H, Li Y, Liu L, Li J, Liu Z . Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China. Tumour Biol. 2015; 37(6):7893-900. DOI: 10.1007/s13277-015-4441-8. View

Li J, Li Y, Huang B, Zheng D, Chen M, Zhou Z . Drug-induced modulation of T lymphocytes as a potential mechanism of susceptibility to infections in patients with multiple myeloma during bortezomib therapy. Cell Biochem Biophys. 2014; 71(1):457-64. PMC: 4289524. DOI: 10.1007/s12013-014-0224-x. View

10.

Sun Y, Huang H, Chen J, Li J, Ma J, Li J . Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China. Tumour Biol. 2014; 36(2):757-67. DOI: 10.1007/s13277-014-2649-7. View

11.

Kurosawa M, Yonezumi M, Hashino S, Tanaka J, Nishio M, Kaneda M . Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol. 2012; 96(6):748-57. DOI: 10.1007/s12185-012-1210-y. View

12.

Wongso D, Fuchs M, Plutschow A, Klimm B, Sasse S, Hertenstein B . Treatment-related mortality in patients with advanced-stage hodgkin lymphoma: an analysis of the german hodgkin study group. J Clin Oncol. 2013; 31(22):2819-24. DOI: 10.1200/JCO.2012.47.9774. View

13.

Nosari A, Pioltelli M, Riva M, Marbello L, Nichelatti M, Greco A . Invasive fungal infections in lymphoproliferative disorders: a monocentric retrospective experience. Leuk Lymphoma. 2013; 55(8):1844-8. DOI: 10.3109/10428194.2013.853299. View

14.

Teng J, Slavin M, Teh B, Lingaratnam S, Ananda-Rajah M, Worth L . Epidemiology of invasive fungal disease in lymphoproliferative disorders. Haematologica. 2015; 100(11):e462-6. PMC: 4825301. DOI: 10.3324/haematol.2015.126698. View

15.

Takaoka K, Nannya Y, Shinohara A, Arai S, Nakamura F, Kurokawa M . A novel scoring system to predict the incidence of invasive fungal disease in salvage chemotherapies for malignant lymphoma. Ann Hematol. 2014; 93(10):1637-44. DOI: 10.1007/s00277-014-2093-1. View